53BP1 and other DNA damage response (DDR) proteins form foci at double-strand breaks (DSBs) which promote their repair by nonhomologous end joining (NHEJ). Focal accumulation of 53BP1 depends on the specific interaction of its tandem Tudor domain with dimethylated lysine 20 in histone H4 (H4K20me2). How 53BP1 foci dynamics are regulated is unclear since H4K20me2 is highly abundant, established largely in the absence of DNA damage, and uncertainty exists about the roles of candidate H4K20 methyltransferases in 53BP1 foci formation. Here, we show that 53BP1 foci assemble primarily on H4K20me2 established prior to DNA damage by the SETD8 and SUV420 methyltransferases rather than de novo H4K20 methylation mediated by MMSET/WHSC1. Moreover, we define a novel role for H4K16 acetylation in regulating 53BP1 foci dynamics. Concurrent acetylation at H4K16 antagonizes 53BP1 binding to extant H4K20me2 until DSBs elicit transient, localized H4 deacetylation that facilitates 53BP1 foci formation and NHEJ, and is associated with global repression of gene transcription. Our findings demonstrate that rapid induction of H4 deacetylation by DSBs affects multiple aspects of the DDR, and also suggest that antagonism of 53BP1 binding to H4K20me2 by H4K16 hyperacetylation may contribute to the efficacy of histone deacetylase inhibitors for cancer therapy.
Introduction
Proper functioning of the DNA damage response (DDR) is critical for maintaining genome integrity and to prevent the acquisition, expression, and transmission of mutated genes (Jackson and Bartek, 2009; Ciccia and Elledge, 2010) . Double-strand DNA breaks (DSBs) are a particularly hazardous type of DNA damage because they can lead to chromosomal rearrangements, cell death, and diseases including cancer if not fully repaired (Jackson and Bartek, 2009; Polo and Jackson, 2011) . Two major DDR pathways, homologous recombination (HR), and nonhomologous end joining (NHEJ) operate in a complementary fashion to repair DSBs. HR requires a homologous template to affect accurate repair and operates during the S and G 2 phases of the cell cycle. In contrast, NHEJ operates throughout the cell cycle and is the predominant DSB repair pathway in higher eukaryotes (Lieber, 2010; Polo and Jackson, 2011) . NHEJ is initiated by the recognition of DNA ends by the Ku70/Ku80 heterodimer, which recruits DNA-dependent protein kinase (DNA-PK) and other factors that are required to effect NHEJ (Jackson and Bartek, 2009; Ciccia and Elledge, 2010; Polo and Jackson, 2011) .
Proteins including 53BP1, MDC1, and BRCA1 that are also recruited to DSBs, assemble into dynamic DNA damageassociated foci that are thought to facilitate NHEJ by enhancing signaling from DNA damage sensing proteins to apical kinases such as ATM and effector kinases including CHK1 and CHK2 (Kastan and Bartek, 2004; FitzGerald et al., 2009) . The mechanisms underlying the formation and disassembly of these foci are only partially understood. Foci are initially marked by phosphatidylinositol 3-OH-kinase-like kinase (PI3KK)-mediated gamma phosphorylation of H2A.X (gH2A.X) to which MDC1 docks via its BRCT domains (Rogakou et al., 1999; Stucki et al., 2005) . Subsequent phosphorylation of MDC1 serves to recruit the E3 ubiquitin ligase RNF8 which ubiquitinates H2A.X and other proteins (Huen et al., 2007; Kolas et al., 2007; Mailand et al., 2007) , leading to the recruitment of 53BP1 by one or more mechanisms that have yet to be defined. The focal accumulation of 53BP1 (Crb2 in Schizosaccharomyces pombe) depends on the specific binding of its tandem Tudor domain to dimethylation at lysine 20 of histone H4 (H4K20me2) (Sanders et al., 2004; Botuyan et al., 2006; Kim et al., 2006; Yang et al., 2008) . However, several factors suggest it is unlikely that the presence of H4K20me2 alone mediates the focal accumulation of 53BP1.
H4K20me2 is highly abundant, accounting for .80% of total H4 in mammalian cells Schotta et al., 2008; Yang et al., 2008) . Most H4K20me2 is established in the absence of DNA damage through monomethylation of newly synthesized H4 at K20 by SETD8 (PR-Set7, SET07, SET8, KMT5A) and successive methylation of H4K20me1 by the SUV420H1 and SUV420H2 (Suv4-20h1/h2, KMT5B/C) methyltransferases to form H4K20me2 and H4K20me3 during normal cell cycle progression (Rice et al., 2002; Pesavento et al., 2008; Schotta et al., 2008; Yang et al., 2008; Oda et al., 2009; Brustel et al., 2011; Kuo et al., 2012) . In contrast to histone modifications like gH2A.X that are induced by DNA damage (Ismail and Hendzel, 2008) , global levels of H4K20me2 do not appear to change following DNA damage (Botuyan et al., 2006; Pei et al., 2011) . Local enhancement of H4K20 methylation at sites of DNA damage by SETD8 (Oda et al., 2010) or MMSET (WHSC1, NSD2) (Hajdu et al., 2011; Pei et al., 2011) has been proposed to regulate 53BP1 foci formation. However, mechanisms that could direct 53BP1 to interact preferentially with this de novo K20 methylation rather than the ubiquitous pre-existing H4K20me2 have not been defined. Clearly, additional factors act to limit 53BP1 binding to the fraction of H4K20me2 that is proximal to DSBs.
Chromatin structure has been proposed to make H4K20me2 inaccessible in the absence of DNA damage, with passive relaxation of chromatin at DSBs and the targeted recruitment of histone acetylation, ubiquitination, and chromatin remodeling activities acting to facilitate focal accumulation of 53BP1 (Sanders et al., 2004; FitzGerald et al., 2009; Stewart, 2009; Xu et al., 2010) . Recently, competitive binding by the hybrid tandem Tudor domains of the JMJD2A and JMJD2B lysine demethylases has been suggested to prevent binding of 53BP1 in the absence of DNA damage, with RNF8-mediated ubiquitination, proteasomal degradation, and rapid depletion of JMJD2A/B from chromatin at damaged sites facilitating focal accumulation of 53BP1 (Mallette et al., 2012) . Although this accounts for the dependence of 53BP1 foci formation on RNF8-mediated ubiquitination, other factors are probably involved because it is unlikely that JMJD2A/B are sufficiently abundant to mask all of the H4K20me2 present in cells.
Here, we demonstrate that transient H4K16 deacetylation is an early response to DSBs, which facilitates 53BP1 foci formation, DSB repair by NHEJ, and repression of transcription. We also investigate the relative importance of the SETD8, SUV420, and MMSET methyltransferases for 53BP1 foci formation and DSB repair by NHEJ.
Results

Rapid induction of H4 deacetylation by DSBs
Increased and decreased H4 acetylation have both been suggested to occur at various times following DNA damage in different experimental systems (Bird et al., 2002; Jazayeri et al., 2004; Gupta et al., 2005; Tamburini and Tyler, 2005; Murr et al., 2006; Alao et al., 2009; Miller et al., 2010; Xu et al., 2010) . We chose to focus on the first hour of the response to DSBs to minimize the possibility of detecting changes in H4 acetylation or H4K20 methylation due to checkpoint activation or other alterations in cell cycle progression. Focal accumulation of 53BP1 and reduced H4K16ac immunostaining were observed in multiple human cell types 1 h after adding the DSB inducer bleocin ( Figure 1A) . Decreased H4K16ac was detectable by immunoblotting 30 min after bleocin addition but recovered to pretreatment levels by 8 h in the continued presence of bleocin and persistent H2A.X-Ser139 phosphorylation (gH2A.X) (Supplementary Figure S1 ). The number of 53BP1 foci formed in individual cells was negatively correlated with their residual H4K16ac immunostaining intensity, suggesting that K16 acetylation antagonizes 53BP1 foci formation ( Figure 1B) . This was also suggested by the finding that bleocin induced less gH2A.X and fewer 53BP1 foci in U2OS cells, a line with higher pretreatment levels of H4K16ac, compared with HeLa cells (Figure 1C and D) . Notably, the global levels of H4K20me1/2/3 were not altered by bleocin treatment. Immunoblots with additional antisera suggest that DSBs induce multisite H4 deacetylation (Supplementary Figure  S2A) . To further investigate the possibility that K16 acetylation antagonizes 53BP1 foci formation, we compared 53BP1 foci formation in HeLa cells expressing wild-type FLAG-H4 or FLAG-H4 with single glutamine substitutions to mimic constitutive acetylation at K5, K8, K12, or K16. 53BP1 foci formation was significantly attenuated in cells expressing the K16Q and K12Q mutants compared with cells expressing either wild type, K5Q, or K8Q FLAG-H4 (Supplementary Figure S2B and C). The significance of H4 modifications at DSBs for 53BP1 foci formation
The multiplicity of DSBs generated by bleocin facilitated the detection of H4K16 deacetylation by immunostaining and immunoblotting ( Figure 1 ), but made it difficult to discern whether deacetylation is localized to DSBs or occurs more globally. To distinguish between these alternatives, we used chromatin immunoprecipitation (ChIP) to monitor 53BP1, H4K16ac, and H4K20me2 dynamics at the single DSB generated by I-SceI nuclease in DR-GFP U2OS cells (Nakanishi et al., 2005) . Similar experiments have provided evidence that MMSET facilitates focal accumulation of 53BP1 by locally enhancing the levels of H4K20me1/2/3 at DSBs (Pei et al., 2011) . DR-GFP U2OS cells expressing the glucocorticoid receptor ligand-binding domain fused to wild-type I-SceI or an inactive point mutant of I-SceI were analyzed 1 h after the addition of dexamethasone to induce nuclear translocation of the respective fusion proteins (Soutoglou et al., 2007) . Consistent with the findings of Pei et al. (2011) , 53BP1 was enriched at the I-SceI site in cells expressing wild-type I-SceI-GR compared with cells expressing inactive 44N-I-SceI-GR ( Figure 2B ). We also found that the level of H4K16ac at this site was reduced in cells expressing active I-SceI-GR, as expected from our data shown in Figure 1 . These changes appeared to be localized to chromatin flanking the DSB created by I-SceI because they were not observed at a distant site (Sat2 in Figure 2B ). In contrast to the findings reported by Pei et al. (2011) , we did not detect a significant change in the level of H4K20me2 at either of the sites assayed ( Figure 2B ). These results suggest that transient, localized H4K16 deacetylation at DSBs facilitates 53BP1 foci formation in the absence of changes in the level of H4K20me2. These findings are further supported by evidence that the level of H4K20me2 within 53BP1 foci resembles that of bulk chromatin, and that 53BP1 foci tend to be excluded from chromatin which is enriched in H4K16ac (Supplementary Figures S3 and S4) .
To further investigate the role of H4K20me2 in 53BP1 recruitment, we compared 53BP1 foci formation in HeLa cells depleted of either MMSET alone or SETD8 + SUV420H1 + SUV420H2 in combination (three-in-one) (Supplementary Figure  S5) . Combined depletion of SETD8 + SUV420H1 + SUV420H2 decreased H4K20me2 levels in immunostaining and immunoblotting, 53BP1 foci formation, and significantly reduced end joining (EJ) activity. In contrast, depletion of MMSET had no effect on these characteristics. The changes in the SETD8 + SUV420H1 + SUV420H2 knockdown cells appear to be attributable to depletion of H4K20me2 rather than nonspecific effects because depletion of these enzymes is not associated with gross alterations in chromatin structure, cell cycle progression, or viability in HeLa or Drosophila S2 cells Yang et al., 2008) , and we did not observe changes in viability or nuclear morphology in these experiments ( Figure 3A and unpublished data). Although it has been reported that de novo formation of H4K20me1 by SETD8 is necessary for 53BP1 foci formation at sites of laser-induced damage (Oda et al., 2010) , we found that accumulation of high levels of H4K20me1 in SUV420H1 + SUV420H2-depleted cells (2-in-1) (Supplementary Figure S7B) (Schotta et al., 2008; Yang et al., 2008) did not rescue 53BP1 foci formation, H4K20me2 immunostaining, or EJ activity (Supplementary Figures S6 and S7) . Together, the data shown in Figure 3 and Supplementary Figures S5 -S7 suggest that H4K20me2 established by the Figure 1 Rapid induction of H4K16 deacetylation by DNA DSBs. (A) U2OS and MCF-7 cells were treated with bleocin (10 mg/ml, 1 h) prior to staining with antisera for 53BP1 and H4K16ac. DNA was stained with TO-PRO-3. (B) Bleocin-treated U2OS cells were subdivided into groups exhibiting low, medium, and high nuclear H4K16ac staining intensity after normalization for DNA content. The average number of 53BP1 foci observed in three independent experiments is plotted for each group. (C) HeLa and U2OS cells were treated with bleocin (10 mg/ml, 1 h) and harvested for immunoblotting with antisera to gH2A.X, H4K16ac, H4K20me1, H4K20me2, H4K20me3, and total histone H3. The average relative levels of gH2A.X and H4K16ac observed in three independent experiments are shown in the bar charts. The relative levels of K20me1, 2, and 3 did not differ significantly between bleocin-treated and untreated cells (bar charts not shown). (D) HeLa and U2OS cells were treated with bleocin (10 mg/ml, 1 h) and then stained with antisera to 53BP1. The mean number of 53BP1 foci (+SEM) determined by analyzing .50 cells for each sample are shown in the bar chart. Similar values in the bar charts are indicated by identical letters whereas an asterisk or different letters indicate those which are significantly different (P , 0.05). Scale bars in micrographs ¼ 10 mm. A.U. ¼ arbitrary units.
SETD8/SUV420H1/SUV420H2 pathway prior to DSB induction by bleocin is more significant for 53BP1 foci formation and NHEJ than H4K20me1 formed by SETD8 or H4K20 methylation purportedly mediated by MMSET. Concurrent H4K16ac suppresses 53BP1 binding to H4K20me2/1
As most K16 acetylation occurs in conjunction with K20 dimethylation , we hypothesized that K16 acetylation antagonizes the binding of the 53BP1 tandem Tudor domain (53BP1-TT) to K20me2 on the same molecule of H4. We tested this hypothesis by comparing the interaction of 53BP1-TT with H4 N-terminal peptides that differed in K16 acetylation and K20 methylation (Supplementary Table S4 ). Consistent with earlier findings (Botuyan et al., 2006) , we found that wildtype 53BP1-TT preferentially bound the K20me2 H4 N-terminal peptide, interacted more weakly with the K20me1 peptide, and displayed negligible binding for the unmodified and K20me3 peptides in an ELISA assay ( Figure 4A ) and a pull-down assay ( Figure 4C) . Strikingly, the interaction of 53BP1-TT with the K20me2 and K20me1 peptides was suppressed by concurrent acetylation at K16 ( Figure 4A and C) , with binding diminished to the background levels observed for the unmodified and K20me3 peptides and a point mutant of 53BP1-TT that abrogates methyl-lysine recognition ( Figure 4B ) (Botuyan et al., 2006) .
Additional evidence further substantiates our hypothesis that H4K16 acetylation regulates 53BP1 foci formation. Increasing the levels of H4K16ac by pretreating U2OS cells with media supplemented with 50 or 100-mM sodium acetate (Wilhelm and McCarty, 1970) reduced 53BP1 foci formation ( Figure 5) . Expression of FLAG-H4(K16Q) led to a marked reduction in 53BP1 foci formation compared with cells expressing wild-type FLAG-H4 or FLAG-H4(K16R) ( Figure 6A and Supplementary Figure S8 ). Finally, we found that butyrate suppressed 53BP1 foci formation more in cells expressing wild-type FLAG-H4 than in cells expressing FLAG-H4(K16R) ( Figure 6B ). Taken together, the data shown in Figures 1-6 suggest that localized H4K16 deacetylation facilitates focal accumulation of 53BP1 on pre-existing H4K20me2, and possibly H4K20me1, at DSBs.
DSB-induced H4K16 deacetylation impacts fundamental processes
The suppression of 53BP1:H4K20me2 interactions by K16 acetylation is likely to affect classical NHEJ and other types of EJ (Dimitrova et al., 2008; FitzGerald et al., 2009) . Consistent with this, we found that cells expressing FLAG-H4(K16Q) displayed less EJ activity than cells expressing FLAG-H4(WT) ( Figure 6C , Supplementary Figures S8 and S9) . EJ was also suppressed in cells expressing FLAG-H4(K16A) or FLAG-H4(K16R), suggesting that normal H4K16 acetylation dynamics may be necessary to attain full EJ activity. This possibility was further supported by the reduced EJ activity observed for U2OS cells exposed to butyrate before and during DSB induction by bleocin (Supplementary Figure S11A) . As K16 acetylation has been implicated in regulating gene transcription (Akhtar and Becker, 2000; ShogrenKnaak et al., 2006) , we used BrUTP to label nascent RNA in control and bleocin-treated cells and discovered that bleocin treatment repressed transcription (Supplementary Figure S11B) . Transcription by both RNAPI and RNAPII and appear to be affected since BrUTP incorporation was reduced in both nucleolar and extranucleolar chromatin. These effects appear to be mediated, at least in part, by K16 deacetylation because less repression was observed in cells expressing FLAG-H4(K16Q) compared with those expressing either wild-type FLAG-H4 or FLAG-H4(K16R) (Supplementary Figure S11C) .
Discussion
Our data suggest that the local levels of H4K20me2 do not change significantly at DSBs after they occur, and that 53BP1 foci assemble primarily on pre-existing H4K20me2, established by the SETD8/SUV420H1/SUV420H2 axis, which is made more accessible by localized H4K16 deacetylation. These findings are However, our results contradict suggestions that 53BP1 foci assemble on de novo H4K20 methylation mediated by SETD8 (Oda et al., 2010) or MMSET/WHSC1 at DSBs (Hajdu et al., 2011; Pei et al., 2011) . Several factors may contribute to these discrepancies. Pei et al. (2011) concluded that increased levels of 53BP1, MMSET, and H4K20me1/2/3 were present at the I-SceI site of DR-GFP HeLa cells 24 h after transfecting cells to express active I-SceI. Hajdu et al. (2011) reported that WHSC1 is necessary for 53BP1 foci formation, decreased global abundance of H4K20me2, and increased global abundance of H4K20me3 in cells exposed to hydroxyurea for 24 h. Although we found that MMSET/WHSC1 was dispensable for 53BP1 foci formation during the first hour of DSB generation by bleocin or I-SceI nuclease, our data do not exclude a role for MMSET/ WHSC1 in regulating 53BP1 foci dynamics at later stages of the DDR. Challenges associated with antibody-based comparisons of H4K20 methylation may also be a factor. Pei et al. (2011) suggest that H4K20me1/2/3 are nearly undetectable at the intact I-SceI site whereas prior evidence demonstrates that these forms, particularly H4K20me2, are distributed widely throughout chromatin and should be readily detected at this site in the absence of DNA damage (Rice et al., 2002; Pesavento et al., 2008; Schotta et al., 2008; Yang et al., 2008; Oda et al., 2009; Brustel et al., 2011; Kuo et al., 2012) . Thus, H4K20me1/2/3 may appear to be elevated at the cut I-SceI site in the experiments of Pei et al. (2011) only because their assay underestimates the levels of H4K20me1/2/3 at the intact I-SceI site. Similarly, the changes in the global levels of H4K20me2/3 observed by Hajdu et al. (2011) contradict prior evidence that global levels of H4K20me1/2/3 are not altered in response to DNA damage (Sanders et al., 2004; Botuyan et al., 2006; Pei et al., 2011) and may be a consequence of the effect of hydroxyurea on cell cycle progression (Miller et al., 2010) . Moreover, evidence that H3K36 or other sites are highly preferred substrates for MMSET suggests that the role of MMSET/WHSC1 in the DDR may not involve methylation of H4K20 (Li et al., 2009; Nimura et al., 2009; Kuo et al., 2011; Martinez-Garcia et al., 2011) . Finally, differences in the type of DNA damage generated by different experimental approaches may also be involved. Our data do not exclude roles for SETD8 or MMSET/WHSC1 in the repair of other types of damage that might be generated in addition to DSBs by laser irradiation.
Multiple lines of evidence presented here suggest that concurrent acetylation at K16 suppresses the binding of 53BP1 to H4K20me2 in the absence of DNA damage and that DSBs induce transient, localized H4K16 deacetylation which facilitates focal accumulation of 53BP1. Although the structural basis for selective recognition of H4K20me2 by the tandem Tudor domains of human 53BP1 and S. pombe Crb2 has been described (Botuyan et al., 2006) , it is unclear how K16ac attenuates their binding to K20me2 since residues N-terminal to Arg19 in H4 were not accounted for in the crystal structure. Nonetheless, our model is consistent with evidence from yeast that H4K16 is deacetylated following DNA damage (Jazayeri et al., 2004; Miller et al., 2010; Tao et al., 2011) , and that expression of H4K16Q sensitizes cells to UV light (Megee et al., 1995; Bird et al., 2002) . The biphasic changes in H4K16ac we observed for longer bleocin treatments (Supplementary Figure S1) are consistent with the reduction and recovery observed for H4K16ac after the induction of DNA damage by laser microirradiation or ionizing radiation (Miller et al., 2010) , although the recovery appears to occur more slowly in our case due to the continued presence of bleocin. This biphasic response may also explain reports that H4K16ac levels are increased 1 h after exposing cells to ionizing radiation (Gupta et al., 2005; Li et al., 2010) . A biphasic response has also been reported for H3K56ac after DNA damage (Miller et al., 2010; Battu et al., 2011) . Our results are also consistent with reports that histone deacetylase (HDAC) activity is required Figure 5 Hyperacetylation at H4K16 suppresses 53BP1 foci formation. (A) U2OS cells were maintained in media supplemented with sodium acetate (NaOAc) for 48 h prior to immunoblotting using antisera to K16ac and histone H3 (loading control). The osmotic pressure of all cultures was adjusted to equivalence using sodium chloride (NaCl). (B) Acetate-treated U2OS cells were exposed to bleocin (10 mg/ml, 1 h) and then stained with antisera to K16ac and 53BP1. for 53BP1 foci formation (Kao et al., 2003) and that perturbation of either HDAC or HAT activity postpones the disassembly of gH2A.X-containing complexes during later stages of the DDR (Kusch et al., 2004; Geng et al., 2006; Ikura et al., 2007) . Given the evidence that hypoacetylation of p53 (Liu et al., 1999; Luo et al., 2001) , Ku70 (Cohen et al., 2004; Jeong et al., 2007; Sundaresan et al., 2008) and NBS1 (Yuan et al., 2007) facilitates DNA repair and cell survival, we suggest that the coordinated deacetylation of H4 and other proteins represents an important aspect of the DDR.
Our evidence that global transcription is repressed following DSB induction is consistent with previous reports that have focused on mechanisms apart from H4K16 deacetylation (de Leseleuc and Denis, 2006; Mantoni et al., 2006; Kruhlak et al., 2007; Shanbhag et al., 2010) . Acetylation is more prevalent at K16 than at other sites in H4 (Thorne et al., 1990; Pesavento et al., 2008) and has been implicated in transcriptional activation (Akhtar and Becker, 2000) , chromatin folding (Shogren-Knaak et al., 2006) , and regulating the formation of euchromatin and heterochromatin (Millar et al., 2004) . Thus, we think it is likely that K16 deacetylation induced by DSBs synergizes with other mechanisms to repress transcription and suppress the generation of mutant transcripts. Our data also suggest that H4K16 deacetylation acts in conjunction with ubiquitination and proteosomal degradation of JMJD2A/B to directly enhance the accessibility of H4K20me2 at DSBs and facilitate focal accumulation of 53BP1 after DNA damage occurs (Mallette et al., 2012) . Given the relatively high abundance of H4K16ac in animal cells (Thorne et al., 1990; Sarg et al., 2004; Pesavento et al., 2008; Phanstiel et al., 2008) , K16 acetylation/deacetylation may predominate over JMJD2A/B synthesis and destruction in regulating the accessibility of H4K20me2. Moreover, evidence that the binding of JMJD2A to the K16Q or K16R point mutants (16Q, 16R) were treated with bleocin (10 mg/ml, 1 h) and then stained with antisera to 53BP1 and the FLAG-tag. The mean number of 53BP1 foci per cell (from .30 cells per group) is plotted in the bar chart. (B) HeLa cells were transfected for 48 h with wild-type FLAG-H4 (WT) or the K16R point mutant and butyrate (10 mM) was applied for the last 16 h. Bleocin was then added (10 mg/ml, 1 h) and cells stained with antisera to 53BP1 and the FLAG-tag. The mean number of 53BP1 foci per cell is plotted in the bar chart. (C) HeLa cells transfected for 48 h with the FLAG-H4 constructs shown were then transfected with linearized pCMV-HA-Venus to assay EJ activity (see Supplementary Figure S9 for assay details). All values represent mean + SEM. Identical letters in the bar charts signify similar values, and differing letters and asterisks indicate values that differ significantly from the respective controls (P , 0.05). Only cells expressing similar levels of FLAG-H4 were included in the analysis. Scale bars in micrographs ¼ 10 mm. An immunoblot comparing the expression attained for each of the FLAG-H4 constructs is shown in Supplementary Figure S8. H4K20me2, like that of 53BP1, is suppressed by concurrent H4 acetylation (Garske et al., 2008) suggests the possibility for crosstalk between these pathways. K16 deacetylation may also coordinate with other ATM-dependent events to facilitate focal accumulation of 53BP1 at DNA damage sites (Huen et al., 2007; Kolas et al., 2007; Mailand et al., 2007) .
A variety of HDAC inhibitors (HDACi) have shown promise for cancer therapy (Venugopal and Evans, 2011) . These reagents have pleiotropic effects, including preferentially enhancing the sensitivity of tumor cells to ionizing radiation and radiomimetic drugs, an effect that has been attributed to chromatin decondensation associated with histone hyperacetylation (Kim et al., 2003) or the effects of hyperacetylating DDR proteins (Chen et al., 2007) . However, the findings presented here suggest that DSBs accumulating as a result of the suppression of NHEJ by HDACi-induced H4K16 hyperacetylation may also contribute to this radiosensitization. Our findings also suggest that suppression of 53BP1 foci formation may provide a useful marker for assessing the efficacy of HDACi treatments and the development of new deacetylase inhibitors, and that 53BP1 itself should be investigated as a possible therapeutic target.
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